18 results on '"Hurvitz, Noa"'
Search Results
2. A second-generation artificial intelligence-based therapeutic regimen improves diuretic resistance in heart failure: Results of a feasibility open-labeled clinical trial
3. Establishing a second-generation artificial intelligence-based system for improving diagnosis, treatment, and monitoring of patients with rare diseases
4. Tickborne Relapsing Fever, Jerusalem, Israel, 2004-2018
5. The Constrained-Disorder Principle Assists in Overcoming Significant Challenges in Digital Health: Moving from “Nice to Have” to Mandatory Systems
6. Factors Associated With Increased Risk of Pediatric Orbital Cellulitis—Who Should Be Scanned?
7. Predicting Weight Loss and Comorbidity Improvement 7 Years Following Laparoscopic Sleeve Gastrectomy: Does Early Weight Loss Matter?
8. Serious Bacterial Infections in Preterm Infants: Should Their Age Be “Corrected”?
9. AN ARTIFICIAL INTELLIGENCE BASED THERAPEUTIC REGIMEN IMPROVES DIURETIC RESISTANCE IN HEART FAILURE
10. Constrained disorder principle-based second-generation algorithms implement quantified variability signatures to improve the function of complex systems
11. Improving the effectiveness of anti-aging modalities by using the constrained disorder principle-based management algorithms
12. Massive Intestinal Bleeding in an Adult with IgA Vasculitis Treated with Intravenous Immunoglobulin
13. A Unique Case of Myositis.
14. The role of Staphylococcus lugdunensis as a pathogen in children: a multicentre retrospective study
15. Clinical Correlates of Early IgG Response in Patients with Mild COVID-19
16. Factors Associated With Increased Risk of Pediatric Orbital Cellulitis—Who Should Be Scanned?
17. Glucosylsphingosine (lyso-Gb1) as a Biomarker for Monitoring Treated and Untreated Children with Gaucher Disease
18. β-Cell DNA Damage Response Promotes Islet Inflammation in Type 1 Diabetes
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.